Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dongyuan Tang"'
Autor:
Li Ling, Jiying Hou, Dandan Liu, Dongyuan Tang, Yanqin Zhang, Qianru Zeng, Heng Pan, Ling Fan
Publikováno v:
Stem Cell Research & Therapy, Vol 13, Iss 1, Pp 1-19 (2022)
Abstract Background Chemotherapy can induce premature ovarian insufficiency (POI). POI causes multiple sequelae and is currently incurable. As shown in our previous studies, systemically transplanted human amnion-derived mesenchymal stem cells (hAD-M
Externí odkaz:
https://doaj.org/article/4fb655dd535d47efb87b08e9b8574904
Autor:
Li Ling, Xiushan Feng, Tianqin Wei, Yan Wang, Yaping Wang, Ziling Wang, Dongyuan Tang, Yanjing Luo, Zhengai Xiong
Publikováno v:
Stem Cell Research & Therapy, Vol 10, Iss 1, Pp 1-18 (2019)
Abstract Background Chemotherapy can induce premature ovarian insufficiency (POI) and reduce fertility in young female patients. Currently, there is no effective therapy for POI. Human amnion-derived mesenchymal stem cells (hAD-MSCs) may be a promisi
Externí odkaz:
https://doaj.org/article/344e759575f74401afeb73ddd1e43d6c
Autor:
Ling Fan, Li Ling, Heng Pan, Dongyuan Tang, Yanqin Zhang, Jiying Hou, Dandan Liu, Qianru Zeng
Background: Chemotherapy can induce premature ovarian insufficiency (POI). POI causes multiple sequelae and is currently incurable. Our previous studies have demonstrated that systemically transplanted human amnion-derived mesenchymal stem cells (hAD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::484d29cf010e3fddf685c591f7b7ca69
https://doi.org/10.21203/rs.3.rs-915986/v1
https://doi.org/10.21203/rs.3.rs-915986/v1
Autor:
Xiushan Feng, Yan Wang, Li Ling, Zhengai Xiong, Ziling Wang, Yanjing Luo, Tianqin Wei, Dongyuan Tang, Yaping Wang
Publikováno v:
Stem Cell Research & Therapy, Vol 10, Iss 1, Pp 1-18 (2019)
Stem Cell Research & Therapy
Stem Cell Research & Therapy
Background Chemotherapy can induce premature ovarian insufficiency (POI) and reduce fertility in young female patients. Currently, there is no effective therapy for POI. Human amnion-derived mesenchymal stem cells (hAD-MSCs) may be a promising seed c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dec0ef9dbcf3d7240b324cfcaf857586
http://link.springer.com/article/10.1186/s13287-019-1136-x
http://link.springer.com/article/10.1186/s13287-019-1136-x
Publikováno v:
Regulatory Toxicology and Pharmacology. 122:104915
With an improvement in the survival rate of cancer patients, chemotherapy-induced premature ovarian insufficiency (POI) is increasingly affecting the quality of life of female patients. Currently, there are many relevant studies using mice as an anim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::518c5eaa370672ee65901e6443e04bfc
https://doi.org/10.1016/j.yrtph.2021.104915
https://doi.org/10.1016/j.yrtph.2021.104915